Evolus, Inc. (EOLS) has a market capitalization of $288.87M and trades at $4.44. The 52-week range is 3.86-12.28.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.6, Earnings Per Share (EPS) of $-0.80, annual revenue of $297.18M.
The stock has a beta of 1.00, operates in the Healthcare sector.